ATE304862T1 - Verwendung einer zusammensetzung enthaltend zumindest ein gnrh-analoges zur behandlung von zwangsneurotischen erkrankungen - Google Patents
Verwendung einer zusammensetzung enthaltend zumindest ein gnrh-analoges zur behandlung von zwangsneurotischen erkrankungenInfo
- Publication number
- ATE304862T1 ATE304862T1 AT99933439T AT99933439T ATE304862T1 AT E304862 T1 ATE304862 T1 AT E304862T1 AT 99933439 T AT99933439 T AT 99933439T AT 99933439 T AT99933439 T AT 99933439T AT E304862 T1 ATE304862 T1 AT E304862T1
- Authority
- AT
- Austria
- Prior art keywords
- ocd
- treatment
- composition containing
- gnrh analog
- neurotic diseases
- Prior art date
Links
- 101000904173 Homo sapiens Progonadoliberin-1 Proteins 0.000 title 1
- 102100024028 Progonadoliberin-1 Human genes 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 abstract 3
- 239000000126 substance Substances 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9802438A SE511005C2 (sv) | 1998-07-07 | 1998-07-07 | Användning av komposition omfattande minst ett ämne inom gruppen GnRH-analoger för framställning av ett läkemedel för behandling av tvångstanke-tvångshandlingssjukdom |
| PCT/SE1999/001218 WO2000001403A1 (en) | 1998-07-07 | 1999-07-05 | USE OF COMPOSITION COMPRISING AT LEAST ONE SUBSTANCE WITHIN THE GROUP GnRH-ANALOGUES FOR TREATMENT OF OBSESSIVE-COMPULSIVE DISORDER (OCD) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE304862T1 true ATE304862T1 (de) | 2005-10-15 |
Family
ID=20411995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99933439T ATE304862T1 (de) | 1998-07-07 | 1999-07-05 | Verwendung einer zusammensetzung enthaltend zumindest ein gnrh-analoges zur behandlung von zwangsneurotischen erkrankungen |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1094830B1 (de) |
| JP (1) | JP2002519386A (de) |
| AT (1) | ATE304862T1 (de) |
| AU (1) | AU4949499A (de) |
| CA (1) | CA2336656A1 (de) |
| DE (1) | DE69927376D1 (de) |
| SE (1) | SE511005C2 (de) |
| WO (1) | WO2000001403A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL147138A0 (en) | 2001-12-17 | 2002-08-14 | Yeda Res & Dev | Methods of and pharmaceutical compositions for modulating cell adhesion, migration and extravasation |
| PL2083811T3 (pl) | 2006-11-22 | 2017-05-31 | Clinical Research Associates, Llc | Sposoby leczenia zespołu downa, zespołu łamliwego chromosomu x oraz autyzmu |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE514606C2 (sv) * | 1998-08-26 | 2001-03-19 | Laekartjaenster I Vaestsverige | Läkemedel innehållande GnRH-analoger för behandling av schizofreni |
-
1998
- 1998-07-07 SE SE9802438A patent/SE511005C2/sv not_active IP Right Cessation
-
1999
- 1999-07-05 JP JP2000557849A patent/JP2002519386A/ja active Pending
- 1999-07-05 WO PCT/SE1999/001218 patent/WO2000001403A1/en not_active Ceased
- 1999-07-05 DE DE69927376T patent/DE69927376D1/de not_active Expired - Lifetime
- 1999-07-05 AT AT99933439T patent/ATE304862T1/de not_active IP Right Cessation
- 1999-07-05 CA CA002336656A patent/CA2336656A1/en not_active Abandoned
- 1999-07-05 EP EP99933439A patent/EP1094830B1/de not_active Expired - Lifetime
- 1999-07-05 AU AU49494/99A patent/AU4949499A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2336656A1 (en) | 2000-01-13 |
| EP1094830B1 (de) | 2005-09-21 |
| EP1094830A1 (de) | 2001-05-02 |
| SE9802438L (sv) | 1999-07-19 |
| AU4949499A (en) | 2000-01-24 |
| SE9802438D0 (sv) | 1998-07-07 |
| JP2002519386A (ja) | 2002-07-02 |
| DE69927376D1 (de) | 2006-02-02 |
| SE511005C2 (sv) | 1999-07-19 |
| WO2000001403A1 (en) | 2000-01-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60027732D1 (de) | Verwendung von anti-rubeola antkörpern zur behandlung von symptomen von erkrankungen des zentralen nervensystems | |
| MXPA03010232A (es) | Compuestos de arilsulfonamida, para el tratamiento de la obesidad, de la diabetes tipo ii y de trastornos del sistema nervioso central. | |
| EA200601798A1 (ru) | Замещенные соединения морфолина для лечения расстройств центральной нервной системы | |
| ATE492279T1 (de) | Bupropinmetaboliten zur behandlung von dementia und anderen zerebrovasckulären erkrankungen | |
| CR6392A (es) | Moduladores de ccr5 | |
| ATE235244T1 (de) | Zusammensetzung zur behandlung und prävention neurologischer und pathopsychologischer krankheiten | |
| DE502004006619D1 (de) | Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson | |
| ATE428413T1 (de) | Neue verwendung von peptidverbindungen zur behandlung ovn zentralen neuropathischen schmerzen | |
| DE69936785D1 (de) | Zellvermittelte genverabreichung durch verwendung von aus muskeln derivierten zellen zur behandlung der knochen-verwandten verletzung oder störung | |
| BR0215395A (pt) | Compostos; processo para a preparação de um composto; composição farmacêutica; e método para o tratamento e/ou profilaxia de doenças que estão relacionadas com o nìvel de glicose no sangue | |
| NO20014241D0 (no) | C16-umettede FP-selektive prostaglandinanaloger | |
| DK1441724T3 (da) | Fremgangsmåde til forögelse af endogene testosteronniveauer | |
| BRPI0408889A (pt) | uso de clusterina para o tratamento e/ou prevenção de doenças neurológicas periféricas | |
| ATE290384T1 (de) | Etherlysophospholipide zur behandlung von chronischen entzündlichen erkrankungen | |
| DE69927376D1 (de) | Verwendung einer zusammensetzung enthaltend zumindest ein gnrh-analoges zur behandlung von zwangsneurotischen erkrankungen | |
| DE69729735D1 (de) | Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen | |
| WO2004047727A3 (en) | Compositions and methods for diagnosing and treating mood disorders | |
| ATE463252T1 (de) | Methode zur behandlung des zentralnervensystems durch applikation von strukturanaloga von igf | |
| ATE262343T1 (de) | Verwendung von gnrh analogen zur behandlung von schizophrenie | |
| ATE285773T1 (de) | Pharmazeutische zusammensetzungen zur behandlung von neurologischen krankheiten | |
| ATE330596T1 (de) | Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen | |
| DE69924284D1 (de) | Verwendung von stimulatoren der neurotrophischen faktoren zur behandlung von neurodegenerativen ophthalmischen krankheiten | |
| DE602004030661D1 (de) | Verwendung von kahalalide verbindungen zur herstellung eines arzneimittels zur behandlung von psoriasis | |
| EA200600115A1 (ru) | Производные 2-аминобензойной кислоты | |
| DE50108711D1 (de) | Verwendung von substituierten 6-dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur therapie der harninkontinenz |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |